{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:04:04Z","timestamp":1791313444893,"version":"4.3.1"},"reference-count":282,"publisher":"American Society for Microbiology","issue":"1","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Microbiol Rev"],"published-print":{"date-parts":[[2010,1]]},"abstract":"<jats:sec>\n                    <jats:title>SUMMARY<\/jats:title>\n                    <jats:p>\n                      The increasing emergence of antimicrobial-resistant organisms, especially methicillin-resistant\n                      <jats:italic>Staphylococcus<\/jats:italic>\n                      <jats:italic>aureus<\/jats:italic>\n                      (MRSA), has resulted in the increased use of rifampin combination therapy. The data supporting rifampin combination therapy in nonmycobacterial infections are limited by a lack of significantly controlled clinical studies. Therefore, its current use is based upon in vitro or in vivo data or retrospective case series, all with major limitations. A prominent observation from this review is that rifampin combination therapy appears to have improved treatment outcomes in cases in which there is a low organism burden, such as biofilm infections, but is less effective when effective surgery to obtain source control is not performed. The clinical data support rifampin combination therapy for the treatment of prosthetic joint infections due to methicillin-sensitive\n                      <jats:italic>S. aureus<\/jats:italic>\n                      (MSSA) after extensive debridement and for the treatment of prosthetic heart valve infections due to coagulase-negative staphylococci. Importantly, rifampin-vancomycin combination therapy has not shown any benefit over vancomycin monotherapy against MRSA infections either clinically or experimentally. Rifampin combination therapy with daptomycin, fusidic acid, and linezolid needs further exploration for these severe MRSA infections. Lastly, an assessment of the risk-benefits is needed before the addition of rifampin to other antimicrobials is considered to avoid drug interactions or other drug toxicities.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/cmr.00034-09","type":"journal-article","created":{"date-parts":[[2010,1,11]],"date-time":"2010-01-11T19:22:47Z","timestamp":1263237767000},"page":"14-34","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":213,"title":["Rifampin Combination Therapy for Nonmycobacterial Infections"],"prefix":"10.1128","volume":"23","author":[{"given":"Graeme N.","family":"Forrest","sequence":"first","affiliation":[{"name":"Portland Veterans Affairs Medical Center"},{"name":"Oregon Health and Science University, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Tamura","sequence":"additional","affiliation":[{"name":"Portland Veterans Affairs Medical Center"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2007.01691.x"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00341-07"},{"key":"e_1_3_2_4_2","first-page":"46","volume":"120","year":"2008","unstructured":"Aepinus, C., E. Adolph, C. von Eiff, A. Podbielski, and M. Petzsch. 2008. Kytococcus schroeteri: a probably underdiagnosed pathogen involved in prosthetic valve endocarditis. Wien. Klin. Wochenschr.120:46-49. (In German.)","journal-title":"Wien. Klin. Wochenschr."},{"key":"e_1_3_2_5_2","first-page":"30","volume":"5","year":"1990","unstructured":"Ampel, N. M., and E. J. Wing. 1990. Legionella infection in transplant patients. Semin. Respir. Infect.5:30-37.","journal-title":"Semin. Respir. Infect."},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365540500372697"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.6.1335"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.21.5.800"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1978.03290080041021"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp060473"},{"key":"e_1_3_2_11_2","first-page":"1185","volume":"44","year":"1996","unstructured":"Asakura, T., K. Aoki, M. Tadokoro, H. Tanaka, and S. Furuta. 1996. A case report of active aortic prosthetic valve endocarditis due to methicillin-resistant Staphylococcus epidermidis. Nippon Kyobu Geka Gakkai Zasshi44:1185-1192. (In Japanese.)","journal-title":"Nippon Kyobu Geka Gakkai Zasshi"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.41.6.2337-2340.2003"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502907-807"},{"key":"e_1_3_2_14_2","first-page":"47","volume":"256","year":"1968","unstructured":"Atlas, E., and M. Turck. 1968. Laboratory and clinical evaluation of rifampicin. Am. J. Med. Sci.256:47-54.","journal-title":"Am. J. Med. Sci."},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31814a586a"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000153812.64956.EF"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00775-08"},{"key":"e_1_3_2_18_2","first-page":"1285","volume":"19","year":"1969","unstructured":"Bals, M. G., and S. Filipescu. 1969. The antistaphylococcal activity of rifampicin. Arzneimittelforschung19:1285-1287.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.8.1661"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.11.2335"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.03.036"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2008.03.003"},{"key":"e_1_3_2_23_2","first-page":"417","volume":"61","year":"2008","unstructured":"Bassetti, M., E. Repetto, E. Righi, S. Boni, M. Diverio, M. P. Molinari, M. Mussap, S. Artioli, F. Ansaldi, P. Durando, G. Orengo, P. F. Bobbio, and C. Viscoli. 2008. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections. J. Antimicrob. Chemother.61:417-420.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_24_2","first-page":"527","volume":"119","year":"1968","unstructured":"Bastin, R., J. C. Pechere, C. Tancrede, D. Sicard, and J. P. Harpey. 1968. Initial results of treament with rifampicin of some septicemic states, 4 of which with endocarditis. Bull. Mem. Soc. Med. Hop. Paris119:527-534. (In French.)","journal-title":"Bull. Mem. Soc. Med. Hop. Paris"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365549709019054"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/151.1.157"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.2.220"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/133.2.206"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2007.11.002"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2005.01230.x"},{"key":"e_1_3_2_31_2","first-page":"1907","volume":"21","year":"1971","unstructured":"Binda, G., E. Domenichini, A. Gottardi, B. Orlandi, E. Ortelli, B. Pacini, and G. Fowst. 1971. Rifampicin, a general review. Arzneimittelforschung21:1907-1977.","journal-title":"Arzneimittelforschung"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1042-3680(18)30556-4"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-003-0722-9"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(97)90134-X"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1086\/595011"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.300.5.530"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.8.1815"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.9.2191"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/24.5.914"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aids.0000183519.45137.a6"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0b013e3283189c07"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(01)00286-0"},{"key":"e_1_3_2_43_2","first-page":"53","volume":"10","year":"2004","unstructured":"Carter, M. 2004. IDV concentrations plummet with rifampicin. IAPAC Mon.10:53.","journal-title":"IAPAC Mon."},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.11.2742"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1985.03350430079030"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1099\/00222615-47-3-197"},{"key":"e_1_3_2_47_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19069"},{"key":"e_1_3_2_48_2","doi-asserted-by":"publisher","DOI":"10.1080\/17453670710014527"},{"key":"e_1_3_2_49_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/27.4.558"},{"key":"e_1_3_2_50_2","first-page":"132","volume":"13","year":"1998","unstructured":"Chow, J. W., and V. L. Yu. 1998. Legionella: a major opportunistic pathogen in transplant recipients. Semin. Respir. Infect.13:132-139.","journal-title":"Semin. Respir. Infect."},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.11.1775"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.12.2611"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2008.10.012"},{"key":"e_1_3_2_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-4453(85)90954-5"},{"key":"e_1_3_2_55_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.12.2798"},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1086\/588298"},{"key":"e_1_3_2_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(95)00044-B"},{"key":"e_1_3_2_58_2","doi-asserted-by":"publisher","DOI":"10.1086\/533595"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5418.1318"},{"key":"e_1_3_2_60_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01455-06"},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2007.00274.x"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/38.5.865"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.8.2655-2658.2003"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.3.720"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.5.1059"},{"key":"e_1_3_2_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2006.11.011"},{"key":"e_1_3_2_67_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/10.Supplement_1.S179"},{"key":"e_1_3_2_68_2","first-page":"1870","volume":"138","year":"1990","unstructured":"Djojosaputro, M., S. S. Mustofa, S. Suryawati, and B. Santoso. 1990. The effects of doses and pre-treatment with rifampicin on the elimination kinetics of metronidazole. Eur. J. Pharmacol.138:1870-1871.","journal-title":"Eur. J. Pharmacol."},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/21.5.633"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2006.tb00191.x"},{"key":"e_1_3_2_71_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002480-200011000-00037"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/18.2.266"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(98)00150-3"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.6.1014"},{"key":"e_1_3_2_75_2","first-page":"1071","year":"1989","unstructured":"Dworkin, R. J., B. L. Lee, M. A. Sande, and H. F. Chambers. 1989. Treatment of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancetii:1071-1073.","journal-title":"Lancet"},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.17.3.484"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clpt.2005.01.020"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1002\/jor.20003"},{"key":"e_1_3_2_79_2","first-page":"201","volume":"15","year":"1985","unstructured":"Eng, R. H., S. M. Smith, F. J. Buccini, and C. E. Cherubin. 1985. Differences in ability of cell-wall antibiotics to suppress emergence of rifampicin resistance in Staphylococcus aureus. J. Antimicrob. Chemother.15:201-207.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_80_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl522"},{"key":"e_1_3_2_81_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2006.08.019"},{"key":"e_1_3_2_82_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01646415"},{"key":"e_1_3_2_83_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.1.174"},{"key":"e_1_3_2_84_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.31.10.1457"},{"key":"e_1_3_2_85_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.6.2237-2245.2005"},{"key":"e_1_3_2_86_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.162.9.985"},{"key":"e_1_3_2_87_2","first-page":"21","volume":"11","year":"1983","unstructured":"Foldes, M., R. Munro, T. C. Sorrell, S. Shanker, and M. Toohey. 1983. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus. J. Antimicrob. Chemother.11:21-26.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.04.008"},{"key":"e_1_3_2_89_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-009-0711-y"},{"key":"e_1_3_2_90_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/40.6.877"},{"key":"e_1_3_2_91_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa053783"},{"key":"e_1_3_2_92_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1984.60.2.0354"},{"key":"e_1_3_2_93_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043252"},{"key":"e_1_3_2_94_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199408113310607"},{"key":"e_1_3_2_95_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/34.2.231"},{"key":"e_1_3_2_96_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.1.196"},{"key":"e_1_3_2_97_2","first-page":"189","volume":"10","year":"1994","unstructured":"Gagnon, R. F., G. K. Richards, and G. B. Kostiner. 1994. Time-kill efficacy of antibiotics in combination with rifampin against Staphylococcus epidermidis biofilms. Adv. Perit. Dial.10:189-192.","journal-title":"Adv. Perit. Dial."},{"key":"e_1_3_2_98_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00987.x"},{"key":"e_1_3_2_99_2","doi-asserted-by":"publisher","DOI":"10.1592\/phco.27.3.476"},{"key":"e_1_3_2_100_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00579-07"},{"key":"e_1_3_2_101_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(10)61632-3"},{"key":"e_1_3_2_102_2","first-page":"772","volume":"40","year":"2005","unstructured":"Ghanem, K. G. 2005. Equivalence between oral and intravenous antibiotics when treating serious staphylococcal infections? Clin. Infect. Dis.40:772-773.","journal-title":"Clin. Infect. Dis."},{"key":"e_1_3_2_103_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(01)00258-9"},{"key":"e_1_3_2_104_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-006-0169-0"},{"key":"e_1_3_2_105_2","unstructured":"Mepron (atovaquone) suspension prescribing information. 2008"},{"key":"e_1_3_2_106_2","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1981.55.4.0633"},{"key":"e_1_3_2_107_2","first-page":"49","volume":"18","year":"2001","unstructured":"G\u00f3mez-Lus, R., F. Adri\u00e1n, R. del Campo, P. G\u00f3mez-Lus, S. S\u00e1nchez, C. Garc\u00eda, and M. C. Rubio. 2001. Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp. Int. J. Antimicrob. Agents18:49-54.","journal-title":"Int. J. Antimicrob. Agents"},{"key":"e_1_3_2_108_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01963838"},{"key":"e_1_3_2_109_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2006.03.029"},{"key":"e_1_3_2_110_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.32.9.1320"},{"key":"e_1_3_2_111_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.1.418-420.2003"},{"key":"e_1_3_2_112_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e318189a7df"},{"key":"e_1_3_2_113_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.29.4.611"},{"key":"e_1_3_2_114_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/4.4.315"},{"key":"e_1_3_2_115_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/20.6.875"},{"key":"e_1_3_2_116_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(96)00070-8"},{"key":"e_1_3_2_117_2","doi-asserted-by":"publisher","DOI":"10.1038\/222273a0"},{"key":"e_1_3_2_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90380-9"},{"key":"e_1_3_2_119_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.12.3764-3767.2003"},{"key":"e_1_3_2_120_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.6.1143"},{"key":"e_1_3_2_121_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.19.2138"},{"key":"e_1_3_2_122_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(86)90147-1"},{"key":"e_1_3_2_123_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1987.00370100170041"},{"key":"e_1_3_2_124_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.inf.0000199320.87812.d9"},{"key":"e_1_3_2_125_2","doi-asserted-by":"publisher","DOI":"10.1086\/381202"},{"key":"e_1_3_2_126_2","first-page":"48","volume":"341","year":"1993","unstructured":"Huengsberg, M., S. Castelino, J. Sherrard, N. O'Farrell, and J. Bingham. 1993. Does drug interaction cause failure of PCP prophylaxis with dapsone? Lancet341:48.","journal-title":"Lancet"},{"key":"e_1_3_2_127_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.9.3.406"},{"key":"e_1_3_2_128_2","unstructured":"Dapsone oral tablet package insert. 2008"},{"key":"e_1_3_2_129_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkg160"},{"key":"e_1_3_2_130_2","doi-asserted-by":"publisher","DOI":"10.1086\/600295"},{"key":"e_1_3_2_131_2","first-page":"1019","volume":"129","year":"1967","unstructured":"Jensen, K. 1967. Combination therapy with antibacterial chemotherapeutic agents in staphylococcal infections. Ugeskr. Laeger129:1019-1030. (In Danish.)","journal-title":"Ugeskr. Laeger"},{"key":"e_1_3_2_132_2","first-page":"1078","year":"1968","unstructured":"Jensen, K. 1968. Methicillin-resistant staphylococci. Lancetii:1078.","journal-title":"Lancet"},{"key":"e_1_3_2_133_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00047-09"},{"key":"e_1_3_2_134_2","doi-asserted-by":"publisher","DOI":"10.1086\/516378"},{"key":"e_1_3_2_135_2","doi-asserted-by":"publisher","DOI":"10.1086\/597469"},{"key":"e_1_3_2_136_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(87)90164-7"},{"key":"e_1_3_2_137_2","doi-asserted-by":"publisher","DOI":"10.1086\/380794"},{"key":"e_1_3_2_138_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.33.8.1184"},{"key":"e_1_3_2_139_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.12.2702"},{"key":"e_1_3_2_140_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90374-2"},{"key":"e_1_3_2_141_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.Supplement_3.S543"},{"key":"e_1_3_2_142_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-98-4-447"},{"key":"e_1_3_2_143_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2524.2005.00530.x"},{"key":"e_1_3_2_144_2","first-page":"1726","volume":"29","year":"2008","unstructured":"Khasawneh, F. A., D. S. Ashcraft, and G. A. Pankey. 2008. In vitro testing of daptomycin plus rifampin against methicillin-resistant Staphylococcus aureus resistant to rifampin. Saudi Med. J.29:1726-1729.","journal-title":"Saudi Med. J."},{"key":"e_1_3_2_145_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/3.3.627"},{"key":"e_1_3_2_146_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.298.15.1763"},{"key":"e_1_3_2_147_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.9.1988"},{"key":"e_1_3_2_148_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0801.010151"},{"key":"e_1_3_2_149_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.177.4050.709"},{"key":"e_1_3_2_150_2","doi-asserted-by":"publisher","DOI":"10.1007\/s004020000242"},{"key":"e_1_3_2_151_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/23.6.831"},{"key":"e_1_3_2_152_2","first-page":"424","volume":"95","year":"1992","unstructured":"Kumar, B. D., C. E. Prasad, and K. Krishnaswamy. 1992. Detection of rifampicin-induced nephrotoxicity by N-acetyl-3-D-glucosaminidase activity. J. Trop. Med. Hyg.95:424-427.","journal-title":"J. Trop. Med. Hyg."},{"key":"e_1_3_2_153_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/119.2.132"},{"key":"e_1_3_2_154_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01378.x"},{"key":"e_1_3_2_155_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2004.09.009"},{"key":"e_1_3_2_156_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-9-674"},{"key":"e_1_3_2_157_2","doi-asserted-by":"publisher","DOI":"10.1086\/520658"},{"key":"e_1_3_2_158_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241090-00004"},{"key":"e_1_3_2_159_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.6.932"},{"key":"e_1_3_2_160_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.34.12.2312"},{"key":"e_1_3_2_161_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.23.4.571"},{"key":"e_1_3_2_162_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1293.2007.00442.x"},{"key":"e_1_3_2_163_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.17.4.658"},{"key":"e_1_3_2_164_2","doi-asserted-by":"publisher","DOI":"10.1086\/596629"},{"key":"e_1_3_2_165_2","first-page":"157","volume":"14","year":"1994","unstructured":"Mascellino, M. T., E. Iona, R. Ponzo, C. M. Mastroianni, and S. Delia. 1994. Infections due to Rhodococcus equi in three HIV-infected patients: microbiological findings and antibiotic susceptibility. Int. J. Clin. Pharmacol. Res.14:157-163.","journal-title":"Int. J. Clin. Pharmacol. Res."},{"key":"e_1_3_2_166_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-196810000-00007"},{"key":"e_1_3_2_167_2","doi-asserted-by":"publisher","DOI":"10.1086\/518655"},{"key":"e_1_3_2_168_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.3.863-868.2003"},{"key":"e_1_3_2_169_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/31.5.731"},{"key":"e_1_3_2_170_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.44.3.1187-1189.2006"},{"key":"e_1_3_2_171_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/140.4.639"},{"key":"e_1_3_2_172_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/22.4.457"},{"key":"e_1_3_2_173_2","doi-asserted-by":"publisher","DOI":"10.1179\/joc.1995.7.6.525"},{"key":"e_1_3_2_174_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200207050-00026"},{"key":"e_1_3_2_175_2","doi-asserted-by":"publisher","DOI":"10.1016\/0954-6111(93)90039-3"},{"key":"e_1_3_2_176_2","doi-asserted-by":"publisher","DOI":"10.1038\/2241280a0"},{"key":"e_1_3_2_177_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2005.11.019"},{"key":"e_1_3_2_178_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.10.2428"},{"key":"e_1_3_2_179_2","unstructured":"Methodology for the serum bactericidal test. 1999"},{"key":"e_1_3_2_180_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.5.1186"},{"key":"e_1_3_2_181_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/29.6.719"},{"key":"e_1_3_2_182_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006057900700304"},{"key":"e_1_3_2_183_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002809502901007"},{"key":"e_1_3_2_184_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200342090-00003"},{"key":"e_1_3_2_185_2","doi-asserted-by":"publisher","DOI":"10.1086\/521894"},{"key":"e_1_3_2_186_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.3.491"},{"key":"e_1_3_2_187_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.3.495"},{"key":"e_1_3_2_188_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/147.2.352"},{"key":"e_1_3_2_189_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-4453(92)91234-3"},{"key":"e_1_3_2_190_2","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1016\/j.ijid.2008.07.008","volume":"13","year":"2009","unstructured":"Orvin, K., E. Bilavsky, E. Weiner, D. S. Shouval, and J. Amir. 2009. Successful antibiotic eradication of Streptococcus pneumoniae infection of a ventriculoatrial shunt. Int. J. Infect. Dis.13:e101-e103.","journal-title":"Int. J. Infect. Dis."},{"key":"e_1_3_2_191_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.8.1764"},{"key":"e_1_3_2_192_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.12.5166-5168.2005"},{"key":"e_1_3_2_193_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200443110-00003"},{"key":"e_1_3_2_194_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000269352.39174.A4"},{"key":"e_1_3_2_195_2","first-page":"410","year":"1970","unstructured":"Peard, M. C., D. G. Fleck, L. P. Garrod, and P. M. Waterworth. 1970. Combined rifampicin and erythromycin for bacterial endocarditis. Br. Med. J.iv:410-411.","journal-title":"Br. Med. J."},{"key":"e_1_3_2_196_2","doi-asserted-by":"publisher","DOI":"10.1159\/000071143"},{"key":"e_1_3_2_197_2","doi-asserted-by":"publisher","DOI":"10.1590\/S1413-86702004000300004"},{"key":"e_1_3_2_198_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.115.1.12"},{"key":"e_1_3_2_199_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.39.10.2289"},{"key":"e_1_3_2_200_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.8.805"},{"key":"e_1_3_2_201_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03040704"},{"key":"e_1_3_2_202_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.24.5.410"},{"key":"e_1_3_2_203_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.6.3.330"},{"key":"e_1_3_2_204_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.2.502-508.2001"},{"key":"e_1_3_2_205_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-127-4-199708150-00002"},{"key":"e_1_3_2_206_2","doi-asserted-by":"publisher","DOI":"10.1007\/s005200050297"},{"key":"e_1_3_2_207_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00350-06"},{"key":"e_1_3_2_208_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.qai.0000214808.75594.73"},{"key":"e_1_3_2_209_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkh104"},{"key":"e_1_3_2_210_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e3181642257"},{"key":"e_1_3_2_211_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl552"},{"key":"e_1_3_2_212_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dki323"},{"key":"e_1_3_2_213_2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.70.5.681"},{"key":"e_1_3_2_214_2","doi-asserted-by":"publisher","DOI":"10.1086\/427950"},{"key":"e_1_3_2_215_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00300-08"},{"key":"e_1_3_2_216_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkl274"},{"key":"e_1_3_2_217_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.1.55-61.2006"},{"key":"e_1_3_2_218_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.5.1714-1718.2003"},{"key":"e_1_3_2_219_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.4.1122-1124.2002"},{"key":"e_1_3_2_220_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/131.4.367"},{"key":"e_1_3_2_221_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-85-1-82"},{"key":"e_1_3_2_222_2","unstructured":"Noxafil (posaconazole) oral suspension (package insert). 2006"},{"key":"e_1_3_2_223_2","doi-asserted-by":"publisher","DOI":"10.1086\/424506"},{"key":"e_1_3_2_224_2","first-page":"97","volume":"15","year":"2004","unstructured":"Schwalm, J. D., P. El-Helou, and C. H. Lee. 2004. Clinical outcome with oral linezolid and rifampin following recurrent methicillin-resistant Staphylococcus aureus bacteremia despite prolonged vancomycin treatment. Can. J. Infect. Dis.15:97-100.","journal-title":"Can. J. Infect. Dis."},{"key":"e_1_3_2_225_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(89)90022-9"},{"key":"e_1_3_2_226_2","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-1744"},{"key":"e_1_3_2_227_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/48.6.927"},{"key":"e_1_3_2_228_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.Supplement_3.S507"},{"key":"e_1_3_2_229_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0339(200102)24:2<129::AID-DC1025>3.0.CO;2-6"},{"key":"e_1_3_2_230_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.50.4.1372-1375.2006"},{"key":"e_1_3_2_231_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18116"},{"key":"e_1_3_2_232_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-005-0023-9"},{"key":"e_1_3_2_233_2","doi-asserted-by":"publisher","DOI":"10.1016\/0732-8893(88)90032-6"},{"key":"e_1_3_2_234_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.48.11.4306-4314.2004"},{"key":"e_1_3_2_235_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.1.1.19"},{"key":"e_1_3_2_236_2","doi-asserted-by":"publisher","DOI":"10.1038\/222341a0"},{"key":"e_1_3_2_237_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2005.06.010"},{"key":"e_1_3_2_238_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/13.suppl_C.57"},{"key":"e_1_3_2_239_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000441-198405000-00018"},{"key":"e_1_3_2_240_2","doi-asserted-by":"publisher","DOI":"10.1179\/joc.2006.18.6.648"},{"key":"e_1_3_2_241_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/20.2.329"},{"key":"e_1_3_2_242_2","first-page":"204","volume":"163","year":"1991","unstructured":"Tebas, P., R. R. Martinez, F. Roman, P. Mendaza, J. C. Rodriguez Diaz, R. Daza, and J. M. de Letona. 1991. Early resistance to rifampin and ciprofloxacin in the treatment of right-sided Staphylococcus aureus endocarditis. J. Infect. Dis.163:204-205.","journal-title":"J. Infect. Dis."},{"key":"e_1_3_2_243_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2007.07.007"},{"key":"e_1_3_2_244_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkn180"},{"key":"e_1_3_2_245_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-3062.2007.00231.x"},{"key":"e_1_3_2_246_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2005.08.014"},{"key":"e_1_3_2_247_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.13.5.759"},{"key":"e_1_3_2_248_2","doi-asserted-by":"publisher","DOI":"10.1086\/425368"},{"key":"e_1_3_2_249_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/25.4.575"},{"key":"e_1_3_2_250_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.Supplement_3.S509"},{"key":"e_1_3_2_251_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.28.4.467"},{"key":"e_1_3_2_252_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/19.3.313"},{"key":"e_1_3_2_253_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.2.524"},{"key":"e_1_3_2_254_2","doi-asserted-by":"publisher","DOI":"10.1086\/323021"},{"key":"e_1_3_2_255_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.27.4.615"},{"key":"e_1_3_2_256_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90418-8"},{"key":"e_1_3_2_257_2","doi-asserted-by":"publisher","DOI":"10.1086\/377239"},{"key":"e_1_3_2_258_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.3.747"},{"key":"e_1_3_2_259_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/17.1.75"},{"key":"e_1_3_2_260_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-5-10"},{"key":"e_1_3_2_261_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/16.3.335"},{"key":"e_1_3_2_262_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.19.6.1089"},{"key":"e_1_3_2_263_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.22.5.920"},{"key":"e_1_3_2_264_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/5.Supplement_3.S407"},{"key":"e_1_3_2_265_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.11.2352"},{"key":"e_1_3_2_266_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(85)90436-X"},{"key":"e_1_3_2_267_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/162.1.96"},{"key":"e_1_3_2_268_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.6.1251"},{"key":"e_1_3_2_269_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.10.2380"},{"key":"e_1_3_2_270_2","first-page":"133","volume":"38","year":"1996","unstructured":"Yee, Y. C., B. Kisslinger, V. L. Yu, and D. J. Jin. 1996. A mechanism of rifamycin inhibition and resistance in Pseudomonas aeruginosa. J. Antimicrob. Chemother.38:133-137.","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_271_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200565080-00005"},{"key":"e_1_3_2_272_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp080206"},{"key":"e_1_3_2_273_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.26.4.575"},{"key":"e_1_3_2_274_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.4.1244-1248.2001"},{"key":"e_1_3_2_275_2","doi-asserted-by":"publisher","DOI":"10.1097\/FTD.0b013e31815c16f5"},{"key":"e_1_3_2_276_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197702010-00005"},{"key":"e_1_3_2_277_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/33.5.959"},{"key":"e_1_3_2_278_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI111305"},{"key":"e_1_3_2_279_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra040181"},{"key":"e_1_3_2_280_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.279.19.1537"},{"key":"e_1_3_2_281_2","doi-asserted-by":"publisher","DOI":"10.1177\/089686088900900402"},{"key":"e_1_3_2_282_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/144.4.365"},{"key":"e_1_3_2_283_2","first-page":"896","volume":"101","year":"1983","unstructured":"Zuravleff, J. J., V. L. Yu, and R. B. Yee. 1983. Ticarcillin-tobramycin-rifampin: in vitro synergy of the triplet combination against Pseudomonas aeruginosa. J. Lab. Clin. Med.101:896-902.","journal-title":"J. Lab. Clin. Med."}],"container-title":["Clinical Microbiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.00034-09","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CMR.00034-09","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,23]],"date-time":"2022-02-23T06:39:47Z","timestamp":1645598387000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CMR.00034-09"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":282,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,1]]}},"alternative-id":["10.1128\/CMR.00034-09"],"URL":"https:\/\/doi.org\/10.1128\/cmr.00034-09","relation":{},"ISSN":["0893-8512","1098-6618"],"issn-type":[{"value":"0893-8512","type":"print"},{"value":"1098-6618","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1]]},"assertion":[{"value":"2010-01-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}